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Abstract
Background: Noroviruses (NoVs) are the most frequent cause of acute gastroenteritis worldwide among people of
all ages and the leading cause of gastrointestinal disease outbreaks in various settings. To clarify the differences in
epidemic situations among different settings, we investigated epidemiological trends and the distribution of NoV
genotypes in Yokohama, Japan.
Methods: Between September 2007 and August 2015, 746 outbreaks of NoV gastroenteritis were reported in
kindergarten/nursery schools (K/Ns), primary schools (PSs), and nursing homes for the aged (NHs). Stool samples
were collected for NoV testing, and the NoV gene was amplified and sequenced to determine the genotype.
Results: During the eight seasons, 248 NoV outbreaks occurred in K/Ns, 274 outbreaks in PSs, and 224 outbreaks in
NHs. These outbreaks occurred throughout the year, except in August, and the number increased in November and
peaked in December. The number of outbreaks that occurred from November to February comprised 76.8 % of all
outbreaks. The outbreaks originated in K/Ns or PSs in every season, except for one season. Five genogroup (G)I and
nine GII genotypes in K/Ns, six GI and 10 GII genotypes in PSs, and three GI and six GII genotypes in NHs were
detected during the eight seasons. GII.4 was the most prevalent genotype in K/Ns and NHs. However, GII.6 was the
most prevalent genotype in PSs. The epidemic genotypes in K/Ns and PSs changed by NoV season, although GII.4
was always predominant in NHs. Moreover, the distribution of genotypes was significantly different between
epidemic and non-epidemic periods in each facility (p < 0.01 for all).
Conclusions: The epidemic situation of NoV outbreaks differs by facility, NoV season, and month. The genotype
distribution is likely dependent on the facility and is significantly different between epidemic and non-epidemic
periods.
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Background
Noroviruses (NoVs) are single-stranded positive-sense
RNA viruses in the family Caliciviridae. Based on their
capsid gene, NoV strains can be classified into six gen-
ogroups (GI–GVI), of which GI, GII, and GIV infect
humans [1]. NoV GI contains nine genotypes, and NoV
GII contains 22 genotypes [2]. Globally, NoV GII strains
are dominant, and GII.4 is reportedly the predominant
NoV genotype [3].
NoVs can spread through contaminated food or
water or from person to person and are highly infec-
tious [1, 4]. They are the most common pathogenic
cause of gastrointestinal disease outbreaks [1]. NoV
outbreaks are common in many settings such as health
care settings, schools, and food services worldwide [5–8].
Waterborne outbreaks have also been reported [9, 10]. In
Yokohama, Japan, NoV outbreaks have occurred in vari-
ous settings annually, mainly in kindergarten/nursery
schools (K/Ns), primary schools (PSs), and nursing homes
for the aged (NHs) [11].
To examine the trends of epidemic NoV infectious
disease, epidemiological studies have been conducted
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focused on the transmission route or setting [5, 7, 12–14].
The relationship between outbreak settings and NoV
genotypes has been also studied [6, 7]. Among these, the
relationship between long-term care facilities or health
care settings and GII.4 has often been reported [6, 14].
Additionally, molecular epidemiological studies involving
systematic surveillance of all age groups and routes of in-
fection have been performed [15]. However, to our know-
ledge, longitudinal studies comparing the epidemiological
and genetic characteristics of NoV outbreaks in K/Ns,
PSs, and NHs have not been reported, especially studies
concerning the difference in genotypes detected in these
facilities between epidemic and non-epidemic periods
using statistical analyses. Moreover, the development of
NoV vaccines is currently underway [16, 17]. Thus, under-
standing the epidemic situation of NoV and the distribu-
tion of genotypes will help to determine the utility of
future vaccines.
To clarify the difference in epidemic situations among
these facilities, we investigated epidemiological trends of
NoV outbreaks in K/Ns, PSs, and NHs that occurred in
Yokohama, Japan. We also performed a genetic analysis
of the strains isolated in these facilities to determine the
distribution of NoV genotypes.
Methods
Sample collection
Outbreaks of gastroenteritis in Japan are reported to
local government public health centers by order of the
Ministry of Health, Labour and Welfare. The local gov-
ernment public health centers then conduct field investi-
gations. Between September 2007 and August 2015, 746
outbreaks of NoV gastroenteritis, suspected to be due to
foodborne or person-to-person transmission, were re-
ported in K/Ns, PSs, and NHs. 3,500 stool samples were
collected for NoV testing by the Health and Social
Welfare Bureau, Yokohama, Japan. The number of K/
Ns, PSs, and NHs in Yokohama was 1,501, 342, and 941,
respectively. The age groups of patients of each facility
were: 0–5 years old in K/Ns, 6–12 years old in PSs, and
over 60 years old in NHs. A NoV outbreak was defined
as two or more cases of acute gastroenteritis within a
week occurring in a given setting, and a NoV season was
defined as the 12-month period from September through
August of each year.
Detection of the NoV gene using real-time RT-PCR
A 10 % stool suspension was prepared by mixing each
stool sample with phosphate-buffered saline, followed by
centrifugation at 10,000 × g for 10 min at 4 °C. Viral
RNA was extracted from the supernatants using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. Real-time RT-PCR
detection of NoV was performed using a Smart-Cycler II
(Cepheid, Sunnyvale, CA, USA) using the QuantiTect
Probe RT-PCR Kit (Qiagen) with separate reactions for
NoV GI and II. The primers and probes used to detect
these viruses have been described elsewhere [18, 19].
RT-PCR for NoV genotyping
One positive specimen selected randomly from each pa-
tient in each NoV outbreak was subjected to gene ampli-
fication of region C (the 5′ end of open reading frame 2)
to determine the genotype. RT-PCR was performed
using the TaKaRa One Step RNA PCR Kit (Takara Bio
Inc., Shiga, Japan). The primers used for PCR have been
described elsewhere [20, 21].
Sequencing and NoV genotyping
The nucleotide sequences of the purified PCR products
(QIAquick PCR Purification Kit, Qiagen) were deter-
mined using the BigDye Terminator Cycle Sequencing
Kit (Applied Biosystems, Foster City, CA, USA) and a
Genetic Analyzer 3130 (Applied Biosystems) according
to the manufacturer’s instructions. The obtained data
were used to determine the genotype using the web-
based Norovirus Genotyping Tool Version 1.0 software
program [22].
Statistical analysis
Statistical analysis was performed using IBM SPSS Sta-
tistics Version 22 (IBM, Armonk, NY, USA). Pearson’s
correlation analysis or Fisher’s exact test was used to
determine significant differences between genotypes in
epidemic and non-epidemic periods. P values < 0.01 were
considered to be statistically significant.
Results
NoV outbreaks in K/Ns, PSs, and NHs
During eight consecutive 12-month periods starting in
September 2007, 248 NoV outbreaks occurred in K/Ns,
274 outbreaks in PSs, and 224 outbreaks in NHs. The
majority of these outbreaks were suspected to be due to
person-to-person transmission by epidemiological inves-
tigation. A summary of the NoV outbreaks in each sea-
son is listed in Table 1. Outbreaks primarily occurred in
K/Ns in the 2010–2011, 2013–2014, and 2014–2015
seasons; in PSs, in the 2007–2008, 2008–2009, and
2009–2010 seasons; and in NHs, in the 2011–2012 and
2012–2013 seasons.
Monthly distribution of NoV outbreaks
The monthly cumulative number of outbreaks in K/Ns,
PSs, and NHs is shown in Fig. 1a. NoV outbreaks oc-
curred throughout the year, except in August, and the
number increased in November and peaked in December.
From November to February (the winter season), the
number of monthly outbreaks accounted for over 10 % of
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the overall total (Fig. 1a). The number of outbreaks
during these 4 months comprised 76.8 % of the overall
total. When we examined the outbreaks in the three facil-
ities, outbreaks in K/Ns mainly occurred in November–
December (Fig. 1a). The number of outbreaks in these
2 months corresponded to 69.8 % of all outbreaks in K/
Ns. After January, the number of outbreaks rapidly de-
clined. Outbreaks in PSs mainly occurred in December
and February (Fig. 1a) and corresponded to 50.4 % of all
outbreaks in PSs. Outbreaks in NHs mainly occurred in
December–January (Fig. 1a) and corresponded to 65.2 %
of all outbreaks in NHs. After February, the number of
outbreaks gradually declined.
The monthly outbreak distribution of each season is
shown in Fig. 1b. In K/Ns, out of eight seasons, six sea-
sons peaked in December. The 2012–2013 season
peaked in November, whereas no clear peak was ob-
served in the 2009–2010 season. The monthly distribu-
tion of outbreaks in PSs differed each season. Out of
eight seasons, five seasons peaked in December and two
seasons peaked in February. However, in the 2014–2015
season, the number of outbreaks peaked in June, which
is early summer in Japan. Of note, outbreaks originated
in K/Ns or PSs in each season, except for the 2013–2014
season (Fig. 1b). Conversely, in NHs, out of eight sea-
sons, five seasons peaked in January. The 2009–2010
season peaked during January–February, and the 2012–
2013 and 2014–2015 seasons peaked in December.
NoV genotypes detected in K/Ns, PSs, and NHs
In K/Ns, 232 (93.5 %) outbreaks were caused by GII, 14
(5.7 %) outbreaks by GI, and two (0.8 %) outbreaks by a
mixture of GI and GII. Similarly, 198 (72.3 %) outbreaks
were caused by GII, 65 (23.7 %) outbreaks by GI, and 11
(4.0 %) outbreaks by a mixture of GI and GII in PSs. In
NHs, 221 (98.7 %) outbreaks were caused by GII, three
(1.3 %) outbreaks were caused by GI, and none was
caused by a mixture of GI and GII. Five GI genotypes
(GI.2, GI.3, GI.4, GI.6, and GI.7) and nine GII genotypes
(GII.2, GII.3, GII.4, GII.5, GII.6, GII.7, GII.12, GII.14,
and GII.17) in K/Ns, six GI (GI.2, GI.3, GI.4, GI.5, GI.6,
and GI.7) and 10 GII (GII.2, GII.3, GII.4, GII.6, GII.7,
GII.12, GII.13, GII.14, GII.15, and GII.17) genotypes in
PSs, and three GI (GI.3, GI.4, and GI.6) and six GII
(GII.2, GII.3, GII.4, GII.6, GII.12, and GII.17) genotypes
in NHs were detected during the eight seasons. GII.4
was the most prevalent genotype in K/Ns and NHs and
corresponded to 40.7 % and 93.8 % of the total, respect-
ively, in each facility. Conversely, GII.3 (23.4 %), GII.6
(12.9 %), GII.14 (6.9 %), and GII.2 (6.0 %) were prevalent
genotypes followed by GII.4 in K/Ns. The eight geno-
types, except GII.4, detected in NHs corresponded to
less than 2 % of the total. However, in PSs, GII.6 was the
most prevalent genotype and corresponded to 19.7 % of
the total. Of note, GII.2 (17.9 %), GII.14 (10.2 %), GII.3
(9.5 %), and GI.4 (8.8 %) were more frequently detected
than GII.4 (8.4 %) in PSs.
Trends of NoV genotypes
We also analyzed the genotypes detected in each season
(Fig. 2a–c). Two to nine genotypes were detected in K/
Ns, 7–13 genotypes in PSs, and 1–5 genotypes in NHs
for each season.
In detail, GII was predominant in all 8 seasons, and
GII.4 was most prevalent in four of the eight seasons in
K/Ns (Fig. 2a). GII.4 accounted for 15.7–90.0 % of out-
breaks in each season. GII.3, GII.4, and GII.6 were equally
dominant in the 2008–2009 season (31.3 % each), and
GII.2 and GII.4 were equally dominant in the 2009–2010
season (30.0 % each). GII.3 was the most prevalent in the
2010–2011 season (68.6 %), and GII.6 was predominant in
the 2013–2014 season (45.6 %). GI accounted for 0–
18.9 % of outbreaks in each season (Fig. 2a).
GII was predominant in seven of the eight seasons,
and alterations in the dominant genotype in each season
were observed in PSs (Fig. 2b). GII.6 was the most
prevalent genotype in the 2008–2009 and 2013–2014
seasons (56.1 % and 65.0 %, respectively), whereas GII.2
Table 1 Summary of NoV outbreaks reported in Yokohama, Japan from September 2007 to August 2015
K/Ns PSs NHs
0–5 years old 6–12 years old >60 years old
Season Outbreaks Tested samples Positive samples Outbreaks Tested samples Positive samples Outbreaks Tested samples Positive samples
2007–2008 10 50 36 33 267 153 28 200 90
2008–2009 16 74 60 41 181 133 21 148 73
2009–2010 10 58 36 43 173 138 17 57 53
2010–2011 51 218 145 47 151 129 21 96 66
2011–2012 28 112 85 21 79 63 34 139 103
2012–2013 39 195 132 24 74 67 58 328 204
2013–2014 57 207 153 40 150 120 25 116 85
2014–2015 37 180 133 25 141 87 20 106 69
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in the 2009–2010 season (44.2 %), GII.3 in the 2010–
2011 season (42.6 %), and GII.14 in the 2011–2012 sea-
son (42.9 %) were most prevalent. GII.2 and GII.14 were
equally dominant in the 2007–2008 season (21.2 %
each). Of note, GII.4 was the most prevalent genotype
only in the 2012–2013 season (41.7 %), which is when a
new GII.4 variant (Sydney 2012) spread worldwide. GI
accounted for 8.5–56.0 % of outbreaks in each season,
and GI was predominant only in the 2014–2015 season.
In this season, GI.3 was the most prevalent genotype
(44.0 %) among all genotypes (Fig. 2b).
Although GII.4 was predominant in NHs, its propor-
tion changed in each season (Fig. 2c). GII.4 comprised
85.7–100 % of the total between the 2007–2008 and
2013–2014 seasons. However, GII.4 accounted for only
65.0 % of the total in the 2014–2015 season, and GII.17
accounted for 20.0 %. The GII.17 strains detected in
this season were phylogenetically similar to strains that
have been reported as a new variant, GII.17 Kawasaki
(Kawasaki308; LC037415), and these strains primarily
circulated in Asia in 2014 and 2015 [23–25].
Analysis of genotypes detected in epidemic and
non-epidemic periods
In this study, we tentatively defined an epidemic period
in Yokohama from November to February in each NoV
season because the number of monthly outbreaks
accounted for over 10 % of the overall total (Fig. 1a). We
conducted a correlation analysis to compare the geno-
types detected in the epidemic period (November to
February) and the non-epidemic period (September,
October, and March–August). As shown in Fig. 3, a sig-
nificant difference in the proportion of genotypes was
observed between epidemic and non-epidemic periods
in each facility (p < 0.01 for all).
In PSs, GII.3, GII.4, and GII.6 were more frequently
detected in the epidemic period (12.8, 11.8, and 25.1 %,
respectively) than the non-epidemic period (2.3, 1.1, and
8.0 %, respectively). Conversely, GII.2, GII.14, and GI
genotypes were more frequently detected in the non-
epidemic period (25.3, 13.8, and 36.8 %, respectively)
than the epidemic period (14.4, 8.6, and 17.6 %, respect-
ively). In K/Ns, GII.3 and GII.4 were more frequently
detected in the epidemic period (25.2 and 48.0 %, re-
spectively) than the non-epidemic period (15.2 and
8.7 %, respectively). Similar to PSs, GII.2, GII.14, and GI
genotypes were more frequently detected in the non-
epidemic period (15.2, 15.2, and 23.9 %, respectively)
than the epidemic period (4.0, 5.0, and 1.5 %,
Fig. 1 NoV outbreaks in K/Ns, PSs, and NHs in Yokohama, Japan,
2007–2015. a Cumulative number of NoV outbreaks. The dashed
line indicates 10 % (N = 74.6) of all outbreaks; b Monthly distribution of
NoV outbreaks
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respectively). In NHs, GII.4 was more frequently
detected in the epidemic period (96.2 %) than the
non-epidemic period (82.5 %). Common to all three
facilities, GII.4 was more frequently detected in the
epidemic period, and GII.other (all GII genotypes ex-
cept GII.2, GII.3, GII.4, GII.6, and GII.14) and GI
genotypes were more frequently detected in the non-
epidemic period (Fig. 3).
Discussion
In this study, we focused on three facilities, K/N, PS,
and NH, and investigated the epidemic situation of NoV
Fig. 2 Distribution of NoV capsid genotypes in (a) K/Ns, (b) PSs, and (c) NHs by season. The bars on the left side of the dashed line indicate GI
genotypes, the bars between the dashed line and the solid line indicate GII genotypes, and the bars on the right side of the solid line indicate
the mixture of GI and GII genotypes. GII.U.D., undetermined genotypes in GII
Fig. 3 Comparison of the distribution of NoV capsid genotypes in epidemic and non-epidemic periods. Epidemic indicates the epidemic period
(November–February), and Non-epidemic indicates the non-epidemic period (September, October, and March–August). GII.U.D., undetermined
genotypes in GII
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outbreaks and distribution of genotypes between 2007
and 2015 in Yokohama, Japan. The number of outbreaks
in these three facilities accounted for approximately 70–
80 % of the total NoV outbreaks reported in Yokohama,
although the magnitude of outbreaks differed in each fa-
cility annually [26]. 76.8 % of the outbreaks in these
three facilities occurred in November–February, and the
highest prevalence of NoV outbreaks was observed in
the winter period. This finding is consistent with other
reports which confirmed the clear winter seasonality of
NoV outbreaks [27]. It is considered that a high number
of NoV cases in winter relate with cold temperatures
and dry conditions in Japan [28].
During September–November, which is the beginning
of the NoV season, the number of outbreaks was highest
in K/Ns, followed by PSs, and NHs. Moreover, outbreaks
originated in K/Ns or PSs in each season, except for one
season. These outbreaks among infants and children
likely led to outbreaks among older people. Various NoV
genotypes are present in the environment such as rivers,
sewage, and food throughout the year, although the
prevalences can fluctuate [29–31]. NoVs can also be
transmitted by asymptomatic people [32]. Younger
people, such as infants and children, may be more sus-
ceptible to many NoV genotypes because they have not
acquired sufficient immunity. Thus, it is likely that NoV
outbreaks initially spread among young people. Add-
itionally, a sharp increase in outbreaks was observed in
K/Ns compared with the other two facilities. In general,
the norovirus load decreases with increasing age, espe-
cially in young children aged <5 years, although the
median norovirus load of any genotype is high [33]. A
higher norovirus load or the environment in K/Ns might
affect the rapid spread of the infection. Furthermore,
especially in K/Ns and NHs, the outbreaks in the 2012–
2013 season occurred earlier than in the other seasons.
This might have been related to the emergence of a new
GII.4 variant (Sydney 2012) [26].
During this study period, 14 genotypes in K/Ns, 16
genotypes in PSs, and nine genotypes in NHs were de-
tected during NoV outbreaks. Sakon et al. also reported
that the number of genotypes detected in children (0–14
years old) was greater than that in older people
(>65 years old) [15]. The proportion of detected geno-
types differed between K/Ns and PSs, although GII.2,
GII.3, GII.4, GII.6, and GII.14 were common epidemic
genotypes in the two facilities. GII.6 was the most
prevalent genotype in PSs, whereas GII.4 was the
most prevalent genotype in K/Ns. Additionally, the
proportion of GI in PSs (23.7 %) was higher than that
in K/Ns (5.7 %). The infants attending K/Ns are in
closer contact with adults than school children, and
GII.4 is the dominant genotype in adult populations
[15]. Moreover, several studies confirmed that GI
genotypes are present in the environment, although
GI genotypes are detected less frequently in clinical
samples than GII genotypes [6, 26, 29, 30, 34]. It is
thus likely that school children come in contact with
various genotypes, including GI genotypes, because
school children have a wider sphere of activity than
infants. Indeed, another study has also reported that
GI strains were found relatively more often in schools
[12]. Conversely, the most prevalent genotype in NHs
was GII.4, which is consistent with other reports on
older people [6, 14, 15, 35]. In NHs, the infectious
route of GII.4 likely occurs through person-to-person
transmission through helpers or visitors. However, it is
unclear why GII.4 is predominant in adults and older
people [14, 15]. Moreover, the genotypes in community-
acquired NoV infections are more heterogeneous than in
nosocomial infection [35]. Thus, the genotype detected in
NHs was homogeneous likely because people in NHs have
limited mobility and live in a confined space.
The epidemic genotypes in K/Ns and PSs changed by
NoV season, whereas GII.4 remained the predominant
genotype in NHs. GII.2, GII.3, GII.6, and GII.14 were de-
tected throughout Yokohama during this study period
[26], and these four genotypes are mainly associated
with sporadic infections in children in some Asian coun-
tries, including Japan [8, 15, 36, 37]. Genotype-specific
herd immunity in infants and young children can last
for years and likely influences the endemic NoV geno-
type(s) in the next season [15]. Moreover, GII.4 was the
most prevalent genotype in PSs only in the 2012–2013
season. The GII.4 Sydney 2012 variant spread worldwide
during this season [6, 26, 38], and it is likely that the
emergence of this variant influenced the epidemic geno-
types not only in K/Ns and NHs, but also in PSs. Thus,
care is needed when new variants emerge because the
infection has a tendency to spread. Conversely, GII.17
rapidly increased in the 2014–2015 season in NHs and
PSs, although GII.17 was rarely detected in Yokohama
previously [26]. Although GII.17 only accounted for two
outbreaks (5.4 %) in K/Ns in the 2014–2015 season,
GII.17 outbreaks accounted for 20 % of the total in this
season in PSs and NHs. The median age of GII.17 cases
was significantly older than that of GII.4 cases, with a
wide age distribution of GII.17 infections in Hong Kong
[24]. Further data collection and analysis are needed
to understand the potential age specificity of patients
infected with GII.17.
Our study also revealed that the proportions of geno-
types detected in each facility were significantly different
between epidemic and non-epidemic periods. GII.4 out-
breaks increased in winter [3], which is consistent with
our result that GII.4 was significantly more frequently
detected in the epidemic period (winter in Yokohama)
in K/Ns, PSs, and NHs. Moreover, it has been reported
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that other GII genotypes, except GII.4, exhibited a
weaker seasonal pattern [12], whereas non-GII.4 out-
breaks caused by person-to-person transmission oc-
curred significantly less in the fall and winter seasons
and significantly more in the spring-summer season [6].
However, in our study, the distribution of GII.2, GII.3,
GII.6, and GII.14 significantly differed between epidemic
and non-epidemic periods. Among these genotypes,
GII.3 occurred significantly more frequently in the
epidemic period in K/Ns and PSs. GII.6 also occurred
significantly more frequently in the epidemic period in
PSs. Thus, some genotypes, except GII.4, exhibited sea-
sonality. Further investigations are necessary to deter-
mine precisely the correlations between genotypes and
outbreak setting and season.
Conclusions
We revealed that the epidemic situation of NoV dif-
fered by facility, NoV season, and month even in the
same geographical area. The distribution of genotype
is likely dependent upon the facility, especially the patient
age. Moreover, our study revealed that the proportions of
genotypes detected in each facility were significantly
different between epidemic and non-epidemic periods.
Understanding the epidemic situation of NoV and the
distribution of genotypes will help to determine the utility
of future vaccines.
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